行情

GCVRZ

GCVRZ

Sanofi FR
NASDAQ

实时行情|Nasdaq Last Sale

0.8706
+0.0001
+0.01%
休市 16:00 02/21 EST
开盘
0.8700
昨收
0.8701
最高
0.8706
最低
0.8700
成交量
8.26万
成交额
--
52周最高
0.8795
52周最低
0.1529
市值
10.88亿
市盈率(TTM)
0.3344
分时
5日
1月
3月
1年
5年

GCVRZ 新闻

更多
  • Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
  • MotleyFool.com · 5小时前
  • Coronavirus highlights the $35 billion vaccine market. Here are the key players
  • CNBC.com · 5小时前
  • A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward
  • MotleyFool.com · 2天前
  • Oscar Health Cuts Co-Pays on About 100 Drugs to $3
  • MotleyFool.com · 2天前

所属板块

制药
+0.60%
制药与医学研究
+0.54%

热门股票

代码
价格
涨跌幅
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

GCVRZ 简况

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.
展开

微牛提供Sanofi SA(NASDAQ-GCVRZ)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的GCVRZ股票新闻,以帮助您做出投资决策。